| |   | | | | By Ed Silverman Adobe Out-of-pocket costs paid by patients rose $4 billion, or 5.3%, last year to $79 billion, according to a new analysis by IQVIA. Read More | | By Nicholas Florko David Goldman/AP Staff at the nation’s health agencies suspect political interference is influencing government policymaking, but they’re not reporting it. Read More | | By Damian Garde and Meg Tirrell and Adam Feuerstein On the latest episode of The Readout LOUD: Can biotech buyouts be bad news? And why can't Novavax meet a deadline? Read More | | Sponsor content by STAT Events Battle scars: The journey from lab to patient's bedside Join STAT on May 3 in Boston to explore the challenges, and the unique opportunities for new approaches, solutions, and partnerships, of the drug development process. This in-person program will bring together a diverse group of individuals to share their perspectives about the drug development process. Stay once the conversation is complete for a networking and cocktail reception with STAT and your fellow attendees. Get your ticket now (and save 40% as a STAT+ subscriber). | | By Angus Chen National Cancer Institute/NIH Some scientists are focusing on an antibody anomaly as possible means for early detection of blood cancers. Others are skeptical. Read More | |
No comments